Home or Office Visit for the Insertion of Implantable Birth Control
- Conditions
- Contraception
- Registration Number
- NCT01816932
- Lead Sponsor
- Case Western Reserve University
- Brief Summary
This is a pilot study in which women who desire an etonogestrel implant will be randomized to either a home or office insertion visit. The purpose of this research is to study the interest in, feasibility of, and rates of insertion for implantable birth control (Implanon®/Nexplanon®) when inserted at home visit appointments compared to standard office visit appointments.
The ultimate goal of the study is to reduce barriers to insertion of the etonogestrel implant and increase consistent and correct contraception use by introducing a previously unexplored method of access, the home visit.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 40
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Insertion rates of implantable birth control Two weeks post-implant insertion at the follow-up telephone call Assess rates of insertion of etonogestrel contraceptive implant in women randomly assigned to home visits or standard office visits.
- Secondary Outcome Measures
Name Time Method Interest in home visit option Within 6-8 weeks of enrollment Questionnaires will be distributed at enrollment (Enrollment Questionnaire) and at the insertion visit (Post-Implant Insertion Questionnaire)
Rates of return for postpartum follow-up Within 6-8 weeks of enrollment Data will be collected via electronic medical records to assess if women returned to clinic for their scheduled postpartum visits.
Trial Locations
- Locations (1)
University Hospitals
🇺🇸Cleveland, Ohio, United States
University Hospitals🇺🇸Cleveland, Ohio, United States